We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-8.84%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.6B
AUM Growth
-$1.88B
Cap. Flow
-$444M
Cap. Flow %
-3.54%
Top 10 Hldgs %
48.35%
Holding
1,050
New
210
Increased
412
Reduced
234
Closed
189

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$49.2M
2
SHLX
Shell Midstream Partners, L.P.
SHLX
+$39.8M
3
BBWI icon
Bath & Body Works
BBWI
+$14.7M
4
PSXP
PHILLIPS 66 PARTNERS LP
PSXP
+$14.5M
5
PPL
PPL Corp
PPL
+$12M

Top Sells

Rank Stock Value
1
ETP
Energy Transfer Partners, L.P.
ETP
+$175M
2
EPD icon
Enterprise Products Partners
EPD
+$115M
3
PDCO
Patterson Companies, Inc.
PDCO
+$48.8M
4
MPLX icon
MPLX
MPLX
+$47.4M
5
WPZ
Williams Partners L.P.
WPZ
+$42M

Sector Composition

Rank Sector Weight
1 Energy 56.01%
2 Healthcare 3.42%
3 Financials 3.23%
4 Materials 2.9%
5 Consumer Discretionary 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLD
801
DELISTED
Cloud Peak Energy Inc
CLD
$375K ﹤0.01%
+128,751
New +$533K
ACC
802
DELISTED
American Campus Communities, Inc.
ACC
$374K ﹤0.01%
9,682
– –
AMH icon
803
American Homes 4 Rent
AMH
$12B
$361K ﹤0.01%
+18,000
New +$358K
EVC icon
804
Entravision Communication
EVC
$983M
$359K ﹤0.01%
+76,314
New +$493K
SIRI icon
805
SiriusXM
SIRI
$10B
$359K ﹤0.01%
5,759
+563
+11% +$33.8K
CPRX
806
DELISTED
Catalyst Pharmaceutical
CPRX
$328K ﹤0.01%
137,441
+26,262
+24% +$87.3K
CMRX
807
DELISTED
Chimerix, Inc.
CMRX
$328K ﹤0.01%
63,099
+10,967
+21% +$55.6K
NERV icon
808
Minerva Neurosciences
NERV
$188M
$324K ﹤0.01%
6,488
+1,127
+21% +$54.2K
HIW icon
809
Highwoods Properties
HIW
$3.71B
$321K ﹤0.01%
7,326
– –
ANSS
810
DELISTED
Ansys
ANSS
$317K ﹤0.01%
2,022
+461
+30% +$73.7K
ZYNE
811
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$316K ﹤0.01%
36,356
+21,337
+142% +$230K
FBRX icon
812
Forte Biosciences
FBRX
$1.12B
$315K ﹤0.01%
71
+12
+20% +$55.6K
V icon
813
Visa
V
$677B
$315K ﹤0.01%
2,632
-3,309
-56% -$401K
NOC icon
814
Northrop Grumman
NOC
$77B
$307K ﹤0.01%
879
-1,764
-67% -$591K
RNAC icon
815
Cartesian Therapeutics
RNAC
$232M
$305K ﹤0.01%
999
+174
+21% +$49.6K
LMT icon
816
Lockheed Martin
LMT
$134B
$304K ﹤0.01%
899
+39
+5% +$13.3K
CALA
817
DELISTED
Calithera Biosciences, Inc
CALA
$300K ﹤0.01%
2,379
+413
+21% +$64.4K
TNL icon
818
Travel + Leisure Co
TNL
$4.54B
$294K ﹤0.01%
5,686
+206
+4% +$11K
BHC icon
819
Bausch Health
BHC
$1.65B
$290K ﹤0.01%
18,225
+2,553
+16% +$47.5K
CB icon
820
Chubb
CB
$140B
$290K ﹤0.01%
+2,122
New +$307K
MTEM
821
DELISTED
Molecular Templates, Inc.
MTEM
$288K ﹤0.01%
2,403
+417
+21% +$62.8K
DFS
822
DELISTED
Discover Financial Services
DFS
$282K ﹤0.01%
3,915
-5,181
-57% -$400K
UNH icon
823
UnitedHealth
UNH
$382B
$280K ﹤0.01%
+1,307
New +$299K
BLUE
824
DELISTED
bluebird bio
BLUE
$270K ﹤0.01%
+122
New +$310K
TTWO icon
825
Take-Two Interactive
TTWO
$43B
$269K ﹤0.01%
2,753
-7,401
-73% -$829K
31 32
33
34 35

Similar funds

PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

ALPS Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, ALPS Advisors held 1,050 positions worth $12.6B, down 13% from $14.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $444M in Q1 2018, closing 189 positions and reducing 234 holdings. Its most notable exit was Patterson Companies, Inc., an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Energy at 56% of assets, down from 58% a quarter earlier, followed by Healthcare and Financials.

Against the trend, ALPS Advisors opened a new position in Eli Lilly worth $47.3M.

  • ALPS Advisors's largest Q1 2018 buy was Eli Lilly: 611,259 shares worth $47.3M.
  • ALPS Advisors added most to Shell Midstream Partners, L.P. in Q1 2018, an estimated $39.8M increase.
  • ALPS Advisors's biggest Q1 2018 reduction was Energy Transfer Partners, L.P., cutting an estimated $175M.
  • ALPS Advisors fully exited Patterson Companies, Inc. in Q1 2018, selling an estimated $48.8M.
  • ALPS Advisors's ten largest holdings make up 48% of its $12.6B portfolio in Q1 2018.
  • ALPS Advisors opened 210 new positions and closed 189 in Q1 2018.
  • ALPS Advisors's portfolio value fell 13% quarter-over-quarter to $12.6B.

Based on ALPS Advisors's 13F filing for Q1 2018, filed 1 May 2018.